Click here for YNHH home page.


Sign up for HealthLINK.

Can we help?

Follow up on this month's He@lthLINK

 


Phone Numbers

Directory assistance
(203) 688-4242

Patient information
(203) 688-4177

Adult emergency
(203) 688-2222

Children's emergency
(203) 688-3333

Admitting
(203) 688-2221

Children's admitting
(203) 688-3331

Psychiatric admitting
(203) 688-9907



Mailing address:
Yale-New Haven Hospital
20 York Street
New Haven, CT
06510-3202





Yale-New Haven Hospital, New Haven, Connecticut, USA HealthLINK: Women's Health

February 10, 2005

News this month
Treating heart failure in adult patients with congenital heart disease

More than half a million Americans with congenital heart disease (CHD) have grown into adulthood. As medical management and surgical procedures continue to improve, those numbers will continue to rise. This relatively new patient population presents special challenges to health care professionals. Congestive heart failure (CHF) is increasingly being seen as a late complication of CHD, and a recent report in the International Journal of Cardiology looked at the effectiveness of applying standard heart failure therapies to patients with CHD.

Congestive heart failure is increasingly being seen as a late complication of congenital heart disease.

Angiotensin converting enzyme inhibitors (ACEIs) and beta-blockers (BBs) are both cornerstones of therapy for heart failure among the general population, and the report's authors—specialists in adult CHD at the Toronto General Hospital in Canada and the Toronto Congenital Cardiac Centre for Adults—hypothesize that these same treatments would benefit adult CHD patients with heart failure.

Existing clinical trial evidence
The authors reviewed existing clinical trial evidence for using ACEIs and BBs in left heart failure. They looked at four ACEI trials and found that evidence supports the finding that ACEIs decrease mortality in heart failure patients—those with severe symptoms as well as those with mild to moderate symptoms.

ACEIs provide benefits
The average reduction in one-year mortality in CHF patients after ACEI therapy is about 16 percent. ACEI therapy also decreased hospitalizations, symptoms and recurrent heart attacks with few serious side effects. A small percentage of patients (3-6 %) experience low blood pressure, dizziness (2-5 %) and coughing (6 %). Liver function can potentially worsen although most trials exclude patients with liver disease.

Beta-blockers provide benefits
Evidence of the benefits of beta-blockers for those with chronic heart failure is even greater than that demonstrated by ACEIs. BBs reduce mortality in mild to moderate heart failure as well as severely affected patients. After one year of therapy, mortality is reduced by 36 percent. Hospitalizations, symptoms and recurrent heart attacks were also reduced. Side effects are minimal when the medication is begun at low doses and gradually increased.

Heart failure different in CHD adults
In spite of the evidence in support of both of these medications in heart failure patients, the authors are hesitant to extrapolate the data to congenital heart disease patients with heart failure for several reasons.

  • The study subjects were much older than the average adult CHD patient.
  • Their mortality rates are much higher.
  • Their most common cause of congestive heart failure is ischemic heart disease, unlike CHD patients.

Unlike, the general heart failure population whose disease is a result of ischemic heart disease, heart failure in CHD patients is a result of many different and complex mechanisms that affect blood circulation and the heart's ability to pump effectively.

Physicians have virtually no clinical trial evidence to guide them in their treatment of adult CHD patients with heart failure.

Because of the diversity and complexity of congenital heart defects, few trials have been conducted that study the effectiveness of various treatments on adult CHD patients with heart failure. The study authors summarize the few that do exist and find all of the existing studies are limited by small size, weak methodology, incomplete follow-up and/or short duration.

Given these limitations, physicians have virtually no clinical trial evidence to guide them in their treatment of adult CHD patients with heart failure. Each must be carefully assessed to determine if any medical or surgical interventions are indicated for the patient's specific heart malformation.

The authors underscore the need for well-designed, randomized controlled trials that may guide clinical practice as the numbers of these patients increase. It is essential for centers that care for these patients to collaborate and for the pharmaceutical industry to support ongoing research to determine if the impressive results of ACEIs and BBs in the general heart failure population can be repeated in those with CHD.



Physician Referral Online
A free and confidential service
of Yale-New Haven Hospital.

Physician Referral Online
Using your own criteria, you can request information from a database of more than 1,000 area physicians who have registered to participate.

Request an appointment
We would be happy to assist you in scheduling an appointment with a member of the hospital's medical staff. Use the link above or call:
203-688-2000
or toll-free
1-888-700-6543
to talk with a referral coordinator.



James Perry, MD portrait.

The emergence of a new patient population

The good news is that improvements in diagnosis and surgery have made it possible to repair most congenital heart defects (CHD). These children are now reaching adulthood with the potential to lead full and active lives. Some experts predict that by 2010, there will be more people with CHD over the age of 18 than there are under age 18.

Improvements in diagnosis and surgery have made it possible to repair most congenital heart defects .”

That is great news, but it is also a big challenge for those of us who care for these adults, as the International Journal of Cardiology report indicates. We do not have much substantive clinical research to guide us, but we are beginning to see the benefits of a multidisciplinary approach for CHD adults emerge.

Falling through the cracks
These adult patients have been at risk of falling through the cracks in our health care system. As children, they are treated by pediatric cardiologists who specialize in the repair and treatment of congenital heart defects.

As they become adults, however, their care often transitions to adult cardiologists trained to care for older adults with cardiovascular disease and heart failure. Between the ages of 20 and 40, these adult survivors of CHD may appear to be doing well. Often they are not followed aggressively since they are not exhibiting acute symptoms.

What we have found, however, is that although these patients may report they're doing “okay,” their heart function may be slowly declining. The signs may not be overt, but when physicians question them closely about their lifestyle and activity level, they find these patients are often leading sedentary lives. We know from what we have learned about older patients with heart failure that the disease develops slowly, well before clear symptoms emerge.

Specialized adult CHD centers offer customized care
These patients are ideal candidates for multidisciplinary care by a team that might include pediatric and adult cardiologists, cardiothoracic surgeons, heart failure specialists and intensive care experts, as well as high-risk obstetricians, genetic counselors and a skilled support team.

Subtle signs…tip us off to the existence of progressing cardiac problems .”

Our adult CHD program at Yale-New Haven Hospital and a handful of others across the country are now focusing on identifying and treating these patients before they present with advanced heart failure 10 or 15 years down the road when the prognosis may not be as hopeful as it might be with earlier care. There are subtle signs—chemical and biological markers—that tip us off to the existence of progressing cardiac problems.

Each patient at our center undergoes a thorough health history and diagnostic assessment. Some patients need no immediate treatment, but benefit from ongoing vigilant care. Others may need pacemakers or those with pacemakers may need them reprogrammed. Some are good candidates for catheter or surgical interventions or medical management to help the heart pump more effectively, to control blood pressure and other conditions that may increase a patient's risk of developing advanced heart failure.

Preventive care
Our goal is to preserve as much heart function as we can for as long as we can. It may be that a small number of these patients will be candidates for heart transplant eventually, but it is much better to delay that step for as long as possible. Good preventive care can do that.

Specialized adult CHD programs also provide patients with education about their disease, including the chances of passing CHD to the next generation. Pregnant women with CHD may benefit from high-risk ob/gyn programs that can provide specialized care as they encounter the changes to their bodies associated with pregnancy that can affect congenital heart disease. It's often wise as well to have a fetal echocardiogram performed to check the fetus' heart for possible defects so that preparations can be made to provide expert care for the baby.

Adult CHD programs also provide access to social service support to help prepare for the medical expenses that CHD adults frequently encounter. Most significant heart conditions require lifelong, expensive health care, which is why it's important to obtain and maintain adequate health care coverage with a policy that lets you access physicians with special expertise in congenital heart disease.


Dr. Perry is chief of pediatric cardiology at Yale-New Haven Children’s Hospital, director of the Adult Congenital Heart Program and a professor of pediatrics at the Yale University School of Medicine.


Spacer.
Subscribe to HealthLink.

Other related links.

Copyright 1999-2008.
Top of Page. Y-NHH. YNHHS. Site Editor.

Home page
Staff directory
Directions and parking
Online resources
Yale New Haven Health System
  Need a doctor?
Search
Comments
Top of page
Yale-New Haven Medical Center